Trials / Completed
CompletedNCT00291109
An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg
Quantitative Real Time PCR in Cytolytic Formalin Fixed Breast Cells Obtained by Periareolar Fine Needle Aspiration. An Ancillary Protocol to a Chemoprevention Trial of Letrozole
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (planned)
- Sponsor
- University of Kansas · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the quantitative real time PCR results of oligonucleotide probes for a number of gene transcription products that may be useful as predictors or indicators of response to letrozole
Detailed description
To assess the quantitative real time PCR results of oligonucleotide probes for a number of gene transcription products (PCNA, cyclin-D1, ER alpha, PR, pS2, 450 aromatase, bcl-2, bax, caspase-3, and VEGFR) that may be useful as predictors or indicators of response to letrozole
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | letrozole 2.5 mg |
Timeline
- Start date
- 2003-01-01
- Completion
- 2005-07-01
- First posted
- 2006-02-13
- Last updated
- 2008-09-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00291109. Inclusion in this directory is not an endorsement.